For Wednesday, January 18th
ELRA, RIGH, STEV, CBIS, ANYI, ENER
Our Stocks to Watch tomorrow include Elray Resources Inc. (OTCBB: ELRA), RightSmile Inc. (OTC: RIGH), Stevia Corp. (OTCBB: STEV), Cannabis Science Inc. (OTCBB: CBIS), AnythingIT Inc. (OTCBB: ANYI) and Energy Conversion Devices Inc. (NASDAQ: ENER).
ELRAY RESOURCES INCORPORATED (OTCBB: ELRA)
"Up 103.70% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/ELRA.php
Elray Resources, Inc. is a junior exploration and development Corporation which has successfully accumulated a portfolio of four highly prospective, heavily mineralized mining tenements in Cambodia and Mexico. Elray Resources primary objective is to source potential and viable projects, conduct geological assessments and seek Joint Venture partners to develop the properties. Elray Resources 100% controlled entity in Cambodia is Angkor Wat Minerals Ltd.
ELRA News:
January 12 - Elray Gaming to Develop a Fantasy Stock Market and Forex Application
Elray Gaming (OTCBB: ELRA) a developer of turnkey gaming products, announced plans to develop a host of social networking and mobile applications for the investor community.
US Gaming Laws
Brian Goodman, CEO of Elray Gaming commented “This is in line with Elray’s overall strategy to offer high tech state of the art gaming products, strengthening the companies positioning to benefit from the inevitable change in gaming legislation in the U.S.A. Last month the U.S. Justice Department issued an opinion that in-state internet gambling does not violate law and states are already working towards legalizing online gambling.”
Mr. Goodman said, “It is inevitable that online gaming in the USA will be allowed in certain States and this will not only be a positive result for Elray but for the gaming community as a whole.”
Elray Gaming is in the process of finalizing a Joint Venture with one of the world’s largest global financial service providers.
Elray Gaming will provide a financial trading platform offering real money financial service trading facilities (non USA) as well as a Fantasy Trading / Social Networking products in Stock, Options and currency markets.
Fantasy Stock Market and Forex Applications
Elray Gaming will launch a suite of products aimed at capitalizing on the rapidly growing Social Network and Fantasy Markets. All products will be accessible via the web as well as smart phones, and will allow a network of active investor community. These products will provide Elray Gaming an additional growth component in its online gaming portfolio, and develop an active network of customers interested in the financial markets.
Elray Gaming strictly complies with all local laws and jurisdictions, and the UIGEA (The USA's Unlawful Internet Gambling Enforcement Act of 2006).
RIGHTSMILE INCORPORATED (OTC: RIGH)
"Up 66.67% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/RIGH.php
Based in Port St. Lucie, Florida, RightSmile, Inc. engages in the distribution of branded and private label Cosmetic Laser Teeth Whitening products. RightSmile® provides an exclusive turn-key Cosmetic Teeth Whitening System designed to complement existing health, beauty and medical businesses. Approved branded retailers become known as SmileShoppes. RightSmile® provides every SmileShoppe (RightSmile® dealers) with State-of-the Art Whitening Technology at no cost to the retailer.
RIGH News:
January 9 - RightSmile, Inc. Confirms Reverse Merger Plans with BG Medical Technologies, Inc.
RightSmile, Inc. (OTC: RIGH) confirms reverse merger plans with BG Medical Technologies, Inc., parent company of popular medical cannabis portal, BudGenius.com.
RightSmile entered into merger discussions in October 2011. Since this time BG Medical has worked to complete an ongoing due diligence study of the public entity and market conditions. Throughout December, RightSmile complied with requests and obligations to prepare the public entity for completion of the merger along with formal exit of the RightSmile management team. Full requirements have now been met to the satisfaction of both companies. Final state and corporate filings in Florida and Nevada are progressing for the respective companies. BG Medical Technologies expects to complete the merger January 18th, 2012 . Name change and symbol change requests are to be filed shortly thereafter.
BudGenius.com has served over 240 caregivers for cannabis testing services in California , and provides safety verification and location services for over 2000 patients daily. The company expects to double businesses served and to increase user traffic to over 10,000 visitors daily by mid 2012. Advertising revenue and consumer loyalty programs are being added in Q1, expecting to increase overall revenue 300% by mid-year.
BG Medical Technologies serves its patient community through analysis of responses collected by the BudGenius.com portal in a method similar to traditional scientific trials by harnessing the power of the social Internet. These responses seek to evaluate treatment effectiveness of specific chemical ratios present within the many varieties of cannabis medicine. The resultant data is utilized by BudGenius.com to help guide patients with specific ailments to cannabis medicine varietals that have been evaluated to have a higher probability of favorable treatment.
Services will be expanded throughout 2012 to include diagnostic-support and treatment-monitoring solutions related to cannabis and herbal remedies. These will be introduced as packaged programs to physicians and qualified naturopaths. A program to formulate patient-specific neutraceutical supplements is also underway, and is expected to be introduced by year's end. Supplements will include cannabis and non-cannabis related herbal compounds.
BG Medical Technologies is committed to providing options to patients seeking alternative and supplement treatment to traditional pharmaceutical therapy for critical ailments and general wellness.
STEVIA CORPORATION (OTCBB: STEV)
"Up 35.06% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/STEV.php
Stevia Corp. is a farm management company focused on best practice agronomic competency in order to deliver high value stevia through proprietary plant breeding, excellent agricultural methodologies and innovative post-harvest techniques. To date, the Company has acquired two grower supply contracts and three nursery fields in Vietnam.
STEV News:
January 11 - Stevia Corp. Advises That Vietnam Gov't Supported Projects Are On-Track for 2012 Completion
Stevia Corp. (OTCBB: STEV) ("Stevia Corp." or the "Company"), a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, is pleased to announce that commitments from regional and national levels of governments are paving the way for the rapid development of stevia trial cultivation farms aimed at grower adoption on a commercial scale.
In order to effectively demonstrate the economic opportunities represented by stevia cultivation, the National Government of Vietnam is providing financial support for the development of 50 Ha of stevia cultivation. Additionally, the Bac Giang provincial government is also supporting a further 20 Ha of stevia cultivation. Both projects are currently on track for completion in 2012.
Stevia Corp.'s local grower partner, Stevia Ventures Corporation ("SVC") of Hanoi, is managing both projects in conjunction with the appropriate government entities and local community farmers. The Vietnam government is supporting the projects with financial subsidies to the farmers to help introduce stevia as a new crop and provide an incentive for these farmers to trial Stevia and demonstrate it as an economically viable alternative crop.
Stevia Corp. is providing the farm management expertise to ensure a successful outcome. Under the terms of the agreement, Stevia Corp. will supply stevia seedlings and additional products and services utilizing its proprietary systems and will also have rights to off-take any non-stevia crops produced by inter/multi-cropping.
Mr. George Blankenbaker, Stevia Corp. President, comments, "Having government support for our efforts to commercialize stevia is a huge benefit providing credibility to the local farmer communities and affirms our decision to begin efforts in Vietnam. The government and institutes at all levels have been supportive and understand the potential economic viability of stevia and this has resulted in a strong resolve to spur the commercial development and create a major economic stimulus for the rural communities."
CANNABIS SCIENCE INCORPORATED (OTCBB: CBIS)
"Up 58.44% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/CBIS.php
Cannabis Science Inc. is at the forefront of medical marijuana research and development. The company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. It is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
CBIS News:
January 12 - Generex Biotechnology and Cannabis Science Look to Make Headway in Lucrative Cancer Drug Market
Five Star Equities Provides Stock Research on Generex Biotechnology & Cannabis Science
Several small cap biotechnology stocks are looking to make a splash in the highly lucrative cancer drug market this year. According to a recent press release issued by Denver-based Cannabis Science, global cancer drug sales are expected to grow at a compounded annual rate of 12 to 15 percent, reaching $75 to $80 billion by 2012. Five Star Equities examines the outlook for companies in the Biotechnology industry and provides equity research on Generex Biotechnology Corporation (OTCBB: GNBT) and Cannabis Science Inc. (OTCBB: CBIS). Access to the full company reports can be found at:
www.fivestarequities.com/GNBT
www.fivestarequities.com/CBIS
Cannabis Science, Inc. is a development stage company engaged in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. Last week the company reported the continuing successful progress by two patients who have been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer and Skin Cancer.
Cannabis Science recently issued its fiscal 2012 earnings guidance. The company says sales for 2012 are forecasted to be $6,846,000, while arguing that the company's revenues have "the potential to increase to $65,740,000 in 2014."
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. The Company's novel Ii-Key Hybrid-based HER-2/neu Peptide Vaccine (AE37) is the subject of an ongoing Phase 2 clinical study in patients with HER-2 expressing breast cancer. Positive interim results from the ongoing Phase 2 study of AE37 were presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in December. The company says that final Phase 2 results are expected at some point this year.
ANYTHINGIT INCORPORATED (OTCBB: ANYI)
"Up 92.31% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/ANYI.php
AnythingIT, Inc. is a United States Government-GSA contracted, CCR-registered small business vendor with Congressional Recommendation for IT Asset Recovery/Trade-in, Forensic DataScrub (Department of Defense 5220.22M certified), Donation Processing, and EPA E-Waste Disposal services. Entering the 19th year of business, AnythingIT services both the commercial Fortune 500 as well as U.S. Government entities out of facilities nationally and globally.
ANYI News:
January 4 - AnythingIT Taps Gail Babitt as Chief Financial Officer Marketwire
AnythingIT, Inc. (OTCBB: ANYI), a leading e-waste recovery, asset disposal, and forensic DataScrub service company, has added Gail Babitt as its Chief Financial Officer.
"The addition of Gail to our team comes at a time when we are looking forward to continued strong growth. We are proud to have someone with her depth of knowledge, experience, and expertise coming on board," stated AnythingIT President and CEO David Bernstein.
Ms. Babitt joins AnythingIT with approximately 20 years of experience as a senior executive. She has a strong background in public company requirements. Prior to joining AnythingIT, Ms. Babitt was a chief financial officer of several publicly traded or private equity backed companies including Inuvo, Inc. (AMEX: INUV), Pamida Stores Operating Co., LLC and Onstream Media Corporation. Ms. Babitt was a founding partner of a successful consulting firm, Envision Management Group, Inc. She began her professional career in the Audit and Assurance practices of Ernst & Young LLP and PricewaterhouseCoopers, LLP ("PwC") and developed expertise in mergers and acquisitions in the Transactions Services practice of PwC in New York.
"I am excited about joining such a forward-looking and innovative company at this next stage of its evolution," stated Ms. Babitt. "AnythingIT has a great story with amazing opportunities ahead of it, and it will be a challenge and a privilege to be a part of that future."
Ms. Babitt is a CPA and received a Bachelor of Science degree in Accounting from Nova Southeastern University, and an MBA from Boston University.
ENERGY CONVERSION DEVICES INCORPORATED (NASDAQ: ENER)
"Up 45.24% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/ENER.php
Energy Conversion Devices, Inc., through its subsidiaries, designs, manufactures, sells, and installs thin-film solar laminates that convert sunlight to renewable energy. It operates in two segments, United Solar Ovonic and Ovonic Materials. The United Solar Ovonic segment provides photovoltaic laminates for commercial and industrial rooftop applications, as well as for residential applications. Its products also offer solutions for low load-bearing rooftops, building-integrated photovoltaics, and building-applied photovoltaics. This segment sells its products principally to roofing materials manufacturers, builders and building contractors, and solar power installers/integrators. The Ovonic Materials segment invents, designs, and develops materials and products based on its materials science technology. It commercializes nickel-metal-hydride (NiMH) batteries and Li-Ion cathode materials technologies. This segment licenses its NiMH battery technology to NiMH battery manufacturers for consumer, transportation, and stationary applications. The company offers its products in Italy, the United States, France, Germany, Japan, China, Saudi Arabia, Spain, Canada, South Korea, Austria, Belgium, Switzerland, and internationally. Energy Conversion Devices, Inc. was founded in 1960 and is headquartered in Auburn Hills, Michigan.
ENER News:
January 13 - Energy Conversion Devices Makes Interest Payment on Notes
Energy Conversion Devices, Inc. (NASDAQ: ENER) (ECD), a leading global provider of lightweight, flexible solar products and systems, today announced that it has made its previously deferred semi-annual interest payment on its 3.00% Convertible Senior Notes due June 2013 (Notes). The payment brings ECD current with its obligations under the Notes.
|
